ICD-10-PCS Tabular Index · Section 0 · FY 2027 093

093 Control - Ear, Nose, Sinus ICD-10-PCS

The 093 code range contains 3 ICD-10-PCS codes for Control procedures on the ear, nose, sinus. 2 of the codes are billable and valid for inpatient claim submission in fiscal year 2027.

✓ Built from the official CMS FY 2027 datasetEffective Oct 1, 2026 – Sep 30, 2027
3
Procedure Codes
2
Billable Codes
093
Characters 1–3
09
Parent Body System

Root Operation Definition

Control: Stopping, or attempting to stop, postprocedural or other acute bleeding.

ICD-10-PCS

Codes in the 093 Range 3 codes · 2 billable

3 of 3 shown
  • 093 Ear, Nose, Sinus, ControlNon-billable header
  • 093K7ZZ Control Bleeding in Nasal Mucosa and Soft Tissue, Via Natural or Artificial Opening
  • 093K8ZZ Control Bleeding in Nasal Mucosa and Soft Tissue, Via Natural or Artificial Opening Endoscopic

About the 093 Code Range

These procedures stop or try to stop acute or postprocedural bleeding in the nasal mucosa, the nose’s lining, and soft tissue.

The fourth character identifies nasal mucosa and soft tissue. The fifth distinguishes entry through a natural or artificial opening with or without endoscopic visualization. The sixth character is No Device, and the seventh is No Qualifier.

Epistaxis means a nosebleed, and the Index directs its control to this table.

Questions About This Page

How many billable codes are in the 093 range?

Of the 3 codes in this range, 2 are billable and valid for inpatient claim submission from October 1, 2026 through September 30, 2027. Table header codes group them but cannot be reported on claims.

What does the 093 range classify?

The range classifies Control procedures, stopping, or attempting to stop, postprocedural or other acute bleeding, performed on the ear, nose, sinus. Each code adds the body part, approach, device, and qualifier in characters four through seven, and links to its own reference page.

Related References

Source: CMS FY 2027 ICD-10-PCS order file and code tables, effective October 1, 2026 through September 30, 2027.